Puma Biotechnology's Licensing Partner Knight Therapeutics Receives Regulatory Approval from Health Canada to Commercialize NERLYNX (neratinib) for Extended Adjuvant...
LOS ANGELES--(BUSINESS WIRE)--Jul 16, 2019--
LOS ANGELES--(BUSINESS WIRE)--Jul 16, 2019--